Navigation Links
Risk factors in hospital readmissions among general surgery patients identified in study
Date:10/25/2012

ATLANTA Identifying risk factors in hospital readmissions could help improve patient care and hospital bottom lines, according to a study recently completed by Georgia State University's Experimental Economics Center and a team from the Emory University School of Medicine.

The study, supported by a $1.2 million, three-year award to Georgia State's Andrew Young School of Policy Studies and Emory School of Medicine from the National Institutes of Health's National Institute on Aging, identifies factors associated with hospital readmission within 30 days after surgery procedures. This is the first phase in a larger collaborative study on discharge decisions. The study findings appeared last month in the Journal of the American College of Surgeons.

"We are working to, first of all, find out the causes of readmission of patients at Emory hospital, and that is the first stage of dealing with the problem," said economist and Experimental Economics Center Director James C. Cox, the lead Georgia State researcher on the project. "Having identified the characteristics of patients who are readmitted, we then start looking for ways to alter practice to bring readmission rates down in the future."

The study reviewed 1,442 patients who underwent general surgery procedures from October 2009 until July 2011 at Emory University Hospital. Of the sample, 163 patients, or 11.3 percent, were readmitted within 30 days of discharge. The study identified three primary causes of readmission: pre-existing conditions, complications developed in the hospital and complications developed post-discharge.

Dr. John F. Sweeney, professor of surgery and chief of the Division of General and Gastrointestinal Surgery, is leading the team of Emory physicians. Assistant Professor Vjollca Sadiraj and Associate Professor Kurt E. Schnier are key research team members at Georgia State.

This study began well before the recent news that, as of this month, hospitals will be penalized for having high numbers of discharged Medicare patients readmitted within 30 days. The penalty is part of the Affordable Care Act and will be calculated by comparing a hospital's readmission rate of certain kinds of patients to national averages.

"[This research] becomes even more important than it was previously now that Medicare has made this a priority," Cox says.

The current stage of research in this ongoing study entails further collaboration with experts in decision-making at Georgia State's Experimental Economics Center to develop decision support software that will help improve outcomes. Reducing readmissions by even a small number can have a significant impact on hospital budgets and operations.

Cox, Sadiraj and Schnier, along with co-researchers at Emory, have already completed laboratory experiments testing their decision support software and are working to analyze that data before another round of testing. The final stage in this research process will be to roll the decision-making software out onto the patient wards.


'/>"/>
Contact: Kathleen Poe Ross
kpoeross@gsu.edu
404-413-1374
Georgia State University
Source:Eurekalert

Related medicine news :

1. Scientists Focus on Factors Behind Asthma Attacks
2. Study examines factors associated with improvement in survival from heart attack in France
3. Source of conflict: Study finds factors that can shape divorced mothers co-parenting experiences
4. Some Improvement in Heart Risk Factors for Americans: CDC
5. Study examines characteristics, risk factors among HIV-positive persons born outside the US
6. Are cardiac risk factors linked to less blood flow to the brain?
7. Gastroenterology, CGH maintain strong 2011 impact factors
8. Mount Sinai finds common factors in autism spectrum disorders, schizophrenia, and bipolar disorder
9. Study identifies factors related to violence in veterans
10. Human factors researcher pushes for safer gas fireplaces
11. Nerve growth factors elevated in pancreatic cancer model
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2016)... ... February 08, 2016 , ... Guruji Mahendra Kumar Trivedi is ... 11th, 2016 in honor of his birthday on February 10th. During this time, ... Trivedi is known by over 250,000 people from over 40 different countries as an ...
(Date:2/8/2016)... ... February 08, 2016 , ... According to research by the ... dental technicians to be certified or obtain continuing education. To increase patient awareness ... In Your Mouth?” campaign to inform dentists and patients about the possible lack ...
(Date:2/7/2016)... Birmingham, Lake Orion, Clarkston, Metamora, Michigan (PRWEB) , ... February 07, ... ... women on Friday in recognition of National Wear Red Day. National Wear Red ... heart disease and stroke in women. Heart disease and stroke cause 1 in 3 ...
(Date:2/7/2016)... ... 2016 , ... Dr. Todd Hobgood , certificated in ... surgical expertise. Technically known as deoxycholic acid or previously as ATX-101, Kybella® ... for reduction of fat below the chin (aka the “double chin”). Medication side ...
(Date:2/6/2016)... ... 2016 , ... US Sports Camps is proud to sponsor the Bay Area ... top non-profit leaders, ultimate organizations, and coaches from around the US. The theme for ... Program Director of Youth and Education, describes this year YUCC as “an important conversation ...
Breaking Medicine News(10 mins):
(Date:2/8/2016)... , Feb. 8, 2016 ... the addition of the "Label-Free Detection ... Forecasts to 2020" report to their ... announced the addition of the "Label-Free ... Global Forecasts to 2020" report to ...
(Date:2/8/2016)... , Feb. 8, 2016  Unilife Corporation ("Unilife" or "Company") ... of injectable drug delivery systems, today announced that it will ... ended December 31, 2015 after market close on February 9, ... conference call to discuss these financial results.    ... --> About Unilife Corporation ...
(Date:2/8/2016)... 8, 2016  Sangamo BioSciences, Inc. (NASDAQ: ... announced that the U.S. Food and Drug Administration ... (IND) application for SB-318, a single treatment strategy ... Type I (MPS I). The SB-318 IND application ... a Phase 1/2 clinical study (SB-318-1502) designed to ...
Breaking Medicine Technology: